Scientists Find Potential Elusive Molecule That Sparks Multiple Sclerosis

Date:

When someone has multiple sclerosis (MS), their immune cells target the nervous system instead of the intruding bacteria and viruses. For a long time, it had been suspected that a self-antigen—a normal molecule in the body that the immune system mistakenly treats as a threat—can trigger MS. Researchers had suspected them to be the proteins in myelin—the nerve insulation that erodes in patients with the disease. Newer work has shifted from what triggers that attack toward repairing the damage, including a furapyrrodole compound that promoted myelin repair in MS mice.

Yet, after years of searching, the molecule responsible still couldn’t be found… until now. The long-sought-out molecule that provokes these immune attacks, called a self-antigen, may have finally been pinpointed by researchers, thus exposing a way towards potential treatments. “The work is monumental, and it’s tantalizing,” said neuroimmunologist Hartmut Wekerle of the Max Planck Institute of Neurobiology in Munich, Germany, who wasn’t connected to the study.

The researchers responsible for finding the molecule are immunologists Roland Martin and Mireia Sospedra of the University Hospital of Zurich in Switzerland and their colleagues. They found it because they decided to research whether there were other candidates, other possible molecules apart from the expected. To do this, they analyzed immune cells known as T cells that came from a patient who died from MS. T cells normally switch on when they encounter protein fragments containing just a few amino acids that belong to an invading microbe. However, they also turn on in people who have MS.

The team tested 200 fragment mixtures, each containing 300 billion varieties of protein shards. They wanted to determine which ones stimulated the patients’ T cells. The two fragments with the strongest effect turned out to be part of a human enzyme called guanosine diphosphate-L-fucose synthase. This enzyme is the one that helps cells remodel sugars that are involved in everything from laying down memories to determining our blood type.

The study also found that T cells from 12 of 31 patients who either had been diagnosed with MS or had shown early symptoms of the disease also reacted to the enzyme. In addition, T cells from four of the eight patients tested responded to a bacterial version of the enzyme—lending credence to the recently proposed idea that intestinal bacteria may help spark the disease. Although, according to immunologist Ashutosh Mangalam of the University of Iowa in Iowa City, “The gut microbiome angle is a bit of a stretch” because some of the bacteria that produce the enzyme are less abundant in MS patients than in healthy people.

multiple sclerosisRegardless, the fact remains that even though guanosine diphosphate-L-fucose synthase is prevalent in the brain, “it has never been a candidate in the past,” says neuroimmunologist Reinhard Hohlfeld of Ludwig Maximilians University in Munich. The discovery, he says, is “a first step in an interesting new direction.” The research has been published in Science Translational Medicine.

If guanosine diphosphate-L-fucose synthase does turn out to be one of the elusive MS self-antigens, it would be possible to dose patients with it. Such a treatment might tame symptoms such as numbness and muscle weakness in much the same way that allergy shots prevent people from reacting to substances like ragweed pollen, for example. Sospedra and her colleagues plan to start testing this strategy with MS patients next year.

Andrea D. Steffen
Andrea D. Steffen
I use the alphabet to paint words that become a beautiful and inspiring image in the reader's mind. I have a Bachelors in Architecture from FAU.

Share post:

Popular

What Hibernators Teach Us About Saving Donor Organs

Put a standard laboratory rat liver on ice for...

Multiple Sclerosis Myelin Repair Advance Restores Movement in Mice

Current treatments for multiple sclerosis can calm an overactive...

Razor-Thin Lithium Anode Battery Hits 504 Wh/kg in Lab Cells

When a headline promises a 504 Wh/kg battery breakthrough,...

Stretchable Sodium-Ion Battery Powers Wearables That Bend and Twist

Wearable devices have become progressively softer, thinner, and closer...